This website is intended for healthcare professionals only

New products

The information in the medicines tracker is based on the Regional Drug and Therapeutics Centre (RDTC) horizon scanning reports, which are intended to inform NHS healthcare professionals about new products available through the NHS and significant changes to current product licences.

MGP is not responsible for the information provided by the RDTC horizon scanning reports. Readers are advised to refer to the relevant summary of product characteristics.

To view the original documents in full, visit the Regional Drug and Therapeutics Centre website at:

Click here to view the changes to licensed indications

Date Generic Brand Additional Information
May 2017 Insulin glargine/lixisenatide Suliqua®▼ View
May 2017 Human normal immunoglobulin Iqymune®▼ View
May 2017 Rituximab (biosimilar) Truxima®▼ View
May 2017 Quetiapine generic View
May 2017 Eluxadoline Truberzi® View
May 2017 Tofacitinib Xeljanz®▼ View
Apr 2017 Pembrolizumab Keytruda®▼ View
Apr 2017 Acetylcysteine generic View
Apr 2017 Olmesartan generic View
Apr 2017 Methotrexate Nordimet® View
Apr 2017 Lidocaine Ralvo® View
Apr 2017 Ceftazidime/avibactam Zavicefta®▼ View
Apr 2017 Everolimus Votubia® View
Apr 2017 Fluticasone/salmeterol Aerivio® Spiromax® View
Mar 2017 Folic acid generic View
Mar 2017 Prednisolone generic View
Mar 2017 Dipyridamole Trolactin® View
Mar 2017 Alectinib Alecensa®▼ View
Mar 2017 Olmesartan generic View
Mar 2017 Baricitinib Olumiant®▼ View